Associations of semen quality with pyrethroids in semen and urine samples of men with oligozoospermia: A cross-sectional study in Samsun, Turkey.


Journal

Toxicology and industrial health
ISSN: 1477-0393
Titre abrégé: Toxicol Ind Health
Pays: England
ID NLM: 8602702

Informations de publication

Date de publication:
Dec 2023
Historique:
medline: 20 11 2023
pubmed: 20 10 2023
entrez: 20 10 2023
Statut: ppublish

Résumé

Pyrethroids (PYRs) may act as endocrine disrupters and lead to infertility. The aim of the study was to analyze the levels of anti-androgenic PYRs (cypermethrin, deltamethrin, and permethrin) and 3-phenoxy benzoic acid (3-PBA), a general metabolite of PYRs, in both semen and urine samples of men with oligozoospermia. The PYRs and 3-PBA metabolite levels in the semen and urine samples of the men were analyzed through GC-MS. The results indicated that the levels of PYRs in the semen samples of the infertile group were significantly higher than those of the fertile group. It was determined that cypermethrin exposure was associated with changes in sperm count and total sperm motility, while permethrin, deltamethrin, and 3-PBA levels were associated with changes in sperm morphology. It was determined that there was a significant negative correlation between semen deltamethrin levels and sperm morphology and sperm count. In addition, exposure of these patients to deltamethrin (range; 1.53-8.02 µg/l) and having farmer parents were determined to increase the risk of infertility. In conclusion, the findings of this study showed that exposure to environmental PYRs may adversely affect semen quality, especially in terms of sperm morphology, in men with oligozoospermia.

Identifiants

pubmed: 37860951
doi: 10.1177/07482337231209356
doi:

Substances chimiques

decamethrin 2JTS8R821G
cypermethrin 1TR49121NP
3-phenoxybenzoic acid 69DC2655VH
Permethrin 509F88P9SZ
Pyrethrins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

754-761

Déclaration de conflit d'intérêts

Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Murat Alagöz (M)

In Vitro Fertilization Unit, Department of Obstetrics and Gynecology, Medical Park Hospital, Samsun, Turkey.

Selma Yazar (S)

Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Istanbul Yeni Yuzyil University, Istanbul, Turkey.

Hale Secilmis Canbay (H)

Department of Analytical Chemistry, Faculty of Science and Literature, Mehmet Akif Ersoy University, Burdur, Turkey.

Abdullah Acıkgöz (A)

Department of Urology, Istinye University School of Medicine, İstanbul, Turkey.

Burcin S Corba (BS)

Department of Statistics, Ondokuz Mayis University, Samsun, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH